GSO Global Clinical Research BV Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Amsterdam Netherlands

Organization Overview

First Clinical Trial
2014
NCT02249091
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

GSO Global Clinical Research BV